NCT05960773
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma No drug interventions treatment 2 recruiting NCT05375825
Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin treatment 1 withdrawn NCT05188859
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma treatment 2 not_yet_recruiting NCT03654833
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma treatment 2 active_not_recruiting NCT02357147
Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM) treatment 2 terminated NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT02303899
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma treatment 2 completed NCT05324436
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM) No drug interventions Not Available Not Available recruiting NCT05455424
Niraparib Efficacy in Patient With Unresectable Mesothelioma treatment 2 active_not_recruiting NCT06299163
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03546426
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies treatment 1 unknown_status NCT05568680
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma treatment 1 recruiting NCT06251310
SW-682 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT05698238
Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours No drug interventions treatment 1 not_yet_recruiting NCT05136677
A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants No drug interventions treatment 2 recruiting NCT05944237
HTL0039732 in Participants With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT02519049
11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM) No drug interventions Not Available Not Available completed NCT05380713
......SMARTEST Trial...... No drug interventions treatment 2 recruiting NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT04823741
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma No drug interventions Not Available Not Available recruiting NCT03068117
Malignant Mesothelioma - Can we Improve Quality of Life No drug interventions supportive_care Not Available completed NCT03393858
Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma No drug interventions treatment 1 / 2 terminated NCT06057935
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma No drug interventions treatment 2 recruiting NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients No drug interventions other 2 recruiting NCT04104776
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas No drug interventions treatment 1 / 2 recruiting NCT06281860
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration No drug interventions treatment 1 recruiting NCT03502746
Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma No drug interventions treatment 2 terminated NCT06566079
Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT00004033
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT00004254
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed treatment 2 completed NCT00066651
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00513877
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT00030745
Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung treatment 2 completed NCT00004183
Capecitabine in Treating Patients With Malignant Mesothelioma treatment 2 completed NCT00062283
Alanosine in Treating Patients With Cancer treatment 2 completed NCT00024271
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer treatment 2 unknown_status NCT01655888
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma treatment 2 unknown_status NCT00253409
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery No drug interventions treatment Not Available unknown_status NCT03558932
IP3R Modulation by Cancer Genes in Mesothelioma No drug interventions Not Available Not Available unknown_status NCT00030459
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma treatment 2 unknown_status NCT00003034
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen treatment 3 unknown_status NCT00020124
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs treatment 1 completed NCT01649024
A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma treatment 2 unknown_status NCT00017186
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma treatment 2 completed NCT03684486
Rehabilitation by Effort for Patients With Advanced Bronchial Cancer No drug interventions supportive_care Not Available completed NCT00019825
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura treatment 1 completed NCT03007030
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery treatment 2 recruiting NCT00770120
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery treatment 2 completed NCT01291420
Dendritic Cell Vaccination for Patients With Solid Tumors No drug interventions treatment 1 / 2 completed NCT00004920
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura treatment 3 completed NCT00006231
Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma No drug interventions treatment 3 completed NCT00541073
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery No drug interventions treatment 2 completed NCT00024076
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer No drug interventions treatment 2 completed NCT00821860
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma No drug interventions treatment 3 completed NCT00334594
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers No drug interventions supportive_care 3 completed NCT00006981
Immunotoxin Therapy in Treating Patients With Advanced Cancer treatment 1 completed NCT06256055
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT03678350
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery No drug interventions treatment 1 active_not_recruiting NCT03852823
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours No drug interventions treatment 1 unknown_status NCT00027508
Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma treatment 2 terminated NCT00003508
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma treatment 2 terminated NCT00054002
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma treatment 2 completed NCT00898547
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 No drug interventions Not Available Not Available terminated NCT02580747
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso No drug interventions treatment 1 unknown_status NCT00897247
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite No drug interventions Not Available Not Available completed NCT00634205
Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma No drug interventions treatment 2 completed NCT02300883
Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients No drug interventions Not Available Not Available completed NCT00354393
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT00053885
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma treatment 2 completed NCT00733252
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease No drug interventions Not Available Not Available withdrawn NCT00002475
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer treatment 2 completed NCT00897442
Collecting Tumor Samples From Patients With Gynecological Tumors No drug interventions Not Available Not Available completed NCT00075699
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma No drug interventions treatment 3 completed NCT00005636
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery treatment 3 completed NCT00458913
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma No drug interventions treatment 2 completed NCT00899613
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia No drug interventions Not Available Not Available unknown_status NCT00509041
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma No drug interventions treatment 2 completed NCT00006216
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma treatment 1 unknown_status NCT00003263
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma treatment 1 completed NCT01655225
A Study of LY3023414 in Participants With Advanced Cancer No drug interventions treatment 1 completed NCT01085630
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy No drug interventions treatment 2 completed NCT00227630
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT00002465
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma treatment 1 / 2 unknown_status NCT00003974
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma treatment 1 completed NCT00372840
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer No drug interventions other Not Available completed NCT05538572
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT00006014
SU5416 in Treating Patients With Malignant Mesothelioma treatment 2 completed NCT03874455
Tazemetostat Expanded Access Program for Adults With Solid Tumors No drug interventions Not Available Not Available no_longer_available NCT00003723
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery treatment 2 completed NCT00002608
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors treatment 2 completed NCT04173338
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma No drug interventions treatment 1 terminated NCT00398138
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma No drug interventions treatment 1 completed NCT06469138
A Phase 1 Study to Investigate 14C-bemcentinib Following Single Oral Administration in Healthy Male Subjects No drug interventions treatment 1 completed NCT03399552
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma treatment 1 / 2 completed NCT04214015
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma No drug interventions Not Available Not Available unknown_status NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies treatment 1 recruiting NCT02555007
Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM No drug interventions treatment 1 completed NCT05228015
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02661659
A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy No drug interventions treatment 1 withdrawn NCT04577326
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma No drug interventions treatment 1 active_not_recruiting NCT01773655
Clinical and Histopathologic Characteristics of BAP1 Mutations No drug interventions Not Available Not Available completed NCT00165503
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate No drug interventions diagnostic 2 terminated NCT01343264
Trimodality Therapy for Malignant Pleural Mesothelioma No drug interventions Not Available Not Available unknown_status NCT05765084
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma No drug interventions treatment 1 / 2 recruiting NCT02436733
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM treatment 2 active_not_recruiting NCT01265433
WT-1 Analog Peptide Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy No drug interventions treatment 2 completed NCT02497053
Four Versus Six Cycles of Pemetrexed/Platinum for MPM treatment 2 unknown_status NCT04201145
Pembrolizumab + Defactinib In Pleural Mesothelioma treatment 1 withdrawn NCT01143545
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas treatment 1 terminated NCT02369198
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC No drug interventions treatment 1 completed NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT04713761
Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma treatment 2 not_yet_recruiting NCT02397928
Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) treatment 2 completed NCT00867711
Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients No drug interventions Not Available Not Available completed NCT02269878
Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma No drug interventions Not Available Not Available completed NCT01870609
Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma treatment 2 terminated NCT00386815
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT02611037
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma treatment 2 active_not_recruiting NCT04525859
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma No drug interventions treatment 1 recruiting NCT02755675
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung No drug interventions Not Available 2 unknown_status NCT01211275
Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma treatment 1 / 2 completed NCT00700336
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) No drug interventions treatment 1 / 2 completed NCT04013334
MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma treatment 2 unknown_status NCT00165516
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate No drug interventions treatment 2 completed NCT02761863
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma No drug interventions Not Available Not Available unknown_status NCT06318286
Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma treatment 2 not_yet_recruiting NCT04897022
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma treatment 1 recruiting NCT05042557
Real World Study of MPM in China No drug interventions Not Available Not Available unknown_status NCT01098266
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed treatment 3 completed NCT05308966
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) No drug interventions Not Available Not Available active_not_recruiting NCT00652574
Dasatinib in Resectable Malignant Pleural Mesothelioma No drug interventions treatment 1 completed NCT05582031
Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers treatment 2 withdrawn NCT03710876
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma treatment 3 active_not_recruiting NCT05425576
OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition treatment 2 not_yet_recruiting NCT01644994
Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma treatment 1 / 2 completed NCT02649829
Autologous Dendritic Cell Vaccination in Mesothelioma No drug interventions treatment 1 / 2 active_not_recruiting NCT01279967
A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 unknown_status NCT02662504
Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT04480372
SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II No drug interventions treatment 2 completed NCT03177668
Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma No drug interventions treatment 1 / 2 completed NCT04775446
Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy No drug interventions Not Available Not Available completed NCT05508555
Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma No drug interventions treatment Not Available recruiting NCT02497508
Nivolumab in Patients With Recurrent Malignant Mesothelioma No drug interventions treatment 2 completed NCT03917043
APG-2449 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas No drug interventions treatment 1 recruiting NCT01865045
Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients No drug interventions Not Available Not Available completed NCT00969098
Response Evaluation in Malignant Pleural Mesothelioma No drug interventions Not Available Not Available unknown_status NCT00571298
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma No drug interventions treatment 1 completed NCT02004028
Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants No drug interventions treatment 2 terminated NCT00886028
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 unknown_status NCT05655078
Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma No drug interventions treatment Not Available recruiting NCT04843007
Alvopem® (Pemetrexed) Safety Assessment No drug interventions Not Available Not Available completed NCT04162015
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma No drug interventions treatment 1 active_not_recruiting NCT01243632
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment No drug interventions treatment 2 completed NCT04334759
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma No drug interventions treatment 3 active_not_recruiting NCT05278975
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma No drug interventions treatment 1 / 2 recruiting NCT01722149
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma No drug interventions treatment 0 completed NCT01721018
Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. No drug interventions treatment 1 / 2 completed NCT00797719
Short Neoadjuvant Hemithoracic IMRT for MPM No drug interventions treatment 1 / 2 active_not_recruiting NCT06037941
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma No drug interventions diagnostic Not Available recruiting NCT02347917
A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma No drug interventions treatment 1 / 2 completed NCT05660616
Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT00272558
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT04400539
The IMmunotherapy Pleural 5-ALA PDT No drug interventions treatment 2 recruiting NCT03412357
MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma. No drug interventions treatment Not Available completed NCT01675765
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma No drug interventions treatment 1 completed NCT01355965
Autologous Redirected RNA Meso-CIR T Cells No drug interventions treatment 1 completed NCT03048474
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT00280982
Dendritic Cell-based Immunotherapy in Mesothelioma No drug interventions treatment 1 completed NCT00738582
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma No drug interventions treatment 2 completed NCT01353482
A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma No drug interventions treatment 1 / 2 withdrawn NCT02194231
ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) No drug interventions treatment 2 completed NCT03269227
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma No drug interventions treatment Not Available recruiting NCT00484276
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT02049060
Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin No drug interventions treatment 1 / 2 completed NCT02639767
Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma No drug interventions treatment 1 withdrawn NCT01212367
Intrapleural Gene Transfer for Pleural Mesothelioma No drug interventions treatment 1 completed NCT03175172
Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM) No drug interventions treatment 2 terminated NCT01486368
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT01024946
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity No drug interventions treatment 2 completed NCT05795595
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02863055
Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma No drug interventions treatment 2 active_not_recruiting NCT00165555
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma No drug interventions treatment 1 completed NCT01890980
Phase II Study of Adjuvant WT-1 Analog Peptide Vaccine in MPM Patients After MSK10-134 No drug interventions treatment 2 active_not_recruiting NCT02672033
Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma No drug interventions treatment Not Available terminated NCT03290183
Confocal Laser Endomicroscopy in Pleural Malignancies No drug interventions Not Available Not Available unknown_status NCT02959463
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma treatment 1 active_not_recruiting NCT01064648
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma treatment 1 / 2 active_not_recruiting NCT01112293
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma No drug interventions treatment 2 completed NCT02399371
Pembrolizumab in Treating Patients With Malignant Mesothelioma No drug interventions treatment 2 active_not_recruiting NCT03126630
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma No drug interventions treatment 1 / 2 active_not_recruiting NCT01241682
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma treatment 1 completed NCT03233724
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas treatment 1 / 2 terminated NCT02603315
Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM) No drug interventions Not Available Not Available completed NCT04177953
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery treatment 2 active_not_recruiting